We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-5.37%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$188M
AUM Growth
-$31.4M
Cap. Flow
-$10.3M
Cap. Flow %
-5.46%
Top 10 Hldgs %
88.37%
Holding
48
New
–
Increased
1
Reduced
2
Closed
8

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$14.4M

Top Sells

Rank Stock Value
1
NABL icon
N-able
NABL
+$16.9M
2
MNDY icon
monday.com
MNDY
+$2.24M
3
PATH icon
UiPath
PATH
+$1.44M
4
HOOD icon
Robinhood
HOOD
+$1.02M
5
TWLO icon
Twilio
TWLO
+$891K

Sector Composition

Rank Sector Weight
1 Technology 51.24%
2 Consumer Discretionary 32.92%
3 Healthcare 9.69%
4 Financials 2.69%
5 Communication Services 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
26
Pliant Therapeutics
PLRX
$66.3M
$531K 0.28%
49,434
– –
EB
27
DELISTED
Eventbrite
EB
$494K 0.26%
102,164
– –
GTM
28
ZoomInfo Technologies
GTM
$967M
$494K 0.26%
38,693
– –
NEUE
29
DELISTED
NeueHealth
NEUE
$287K 0.15%
52,720
– –
QS icon
30
QuantumScape Corp
QS
$3.18B
$278K 0.15%
56,499
– –
OPEN icon
31
Opendoor
OPEN
$3.8B
$85.9K 0.05%
48,264
– –
IPSC icon
32
Century Therapeutics
IPSC
$370M
$74K 0.04%
29,018
– –
RPTX
33
DELISTED
Repare Therapeutics
RPTX
$40.5K 0.02%
12,276
– –
MCRB icon
34
Seres Therapeutics
MCRB
$46.5M
$35.7K 0.02%
2,468
– –
PACB icon
35
Pacific Biosciences
PACB
$432M
$32.2K 0.02%
23,484
– –
RLYB icon
36
Rallybio
RLYB
$85.7M
$29.3K 0.02%
2,735
– –
PMVP icon
37
PMV Pharmaceuticals
PMVP
$58.7M
$18.7K 0.01%
11,533
– –
NXTC icon
38
NextCure
NXTC
$22.1M
$16K 0.01%
837
– –
ALGS icon
39
Aligos Therapeutics
ALGS
$26.3M
$6.57K ﹤0.01%
751
– –
ASTR
40
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$6.26K ﹤0.01%
12,444
– –
CPNG icon
41
Coupang
CPNG
$27.7B
– –
-26,834
Closed -$477K
DASH icon
42
DoorDash
DASH
$85.2B
– –
-2,505
Closed -$345K
HOOD icon
43
Robinhood
HOOD
$83.3B
– –
-50,685
Closed -$1.02M
MNDY icon
44
monday.com
MNDY
$3.68B
– –
-9,901
Closed -$2.24M
NABL icon
45
N-able
NABL
$818M
– –
-1,293,572
Closed -$16.9M
PATH icon
46
UiPath
PATH
$6.32B
– –
-63,700
Closed -$1.44M
PINS icon
47
Pinterest
PINS
$13.6B
– –
-21,310
Closed -$739K
TWLO icon
48
Twilio
TWLO
$29.5B
– –
-14,572
Closed -$891K
1
2

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Harbourvest Partners held 48 positions worth $188M, down 14% from $219M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Harbourvest Partners withdrew a net $10.3M in Q2 2024, closing 8 positions and reducing 2 holdings. Its most notable exit was N-able, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Harbourvest Partners added an estimated $14.4M to HashiCorp, Inc. Class A Common Stock.

  • Harbourvest Partners added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $14.4M increase.
  • Harbourvest Partners's biggest Q2 2024 reduction was Affirm, cutting an estimated $495K.
  • Harbourvest Partners fully exited N-able in Q2 2024, selling an estimated $16.9M.
  • Harbourvest Partners's ten largest holdings make up 88% of its $188M portfolio in Q2 2024.
  • Harbourvest Partners opened 0 new positions and closed 8 in Q2 2024.
  • Harbourvest Partners's portfolio value fell 14% quarter-over-quarter to $188M.

Based on Harbourvest Partners's 13F filing for Q2 2024, filed 14 Aug 2024.